<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains a major cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Murine models have yielded critical insights into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> pathogenesis, but they often fail to recapitulate advanced-disease phenotypes, notably <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:mp ids='MP_0008866'>chromosomal instability</z:mp> (CIN) </plain></SENT>
<SENT sid="2" pm="."><plain>New models are thus needed to understand disease progression and to develop therapies </plain></SENT>
<SENT sid="3" pm="."><plain>We sought to model advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> by inactivating two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors that are mutated in human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, the Fbw7 ubiquitin ligase and p53 </plain></SENT>
<SENT sid="4" pm="."><plain>Here we report that Fbw7 deletion alters differentiation and proliferation in the gut epithelium and stabilizes oncogenic Fbw7 substrates, such as cyclin E and Myc </plain></SENT>
<SENT sid="5" pm="."><plain>However, Fbw7 deletion does not cause <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in the gut </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, codeletion of both Fbw7 and p53 causes highly penetrant, aggressive, and metastatic <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, and allografts derived from these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> form highly malignant <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>In vitro evidence indicates that Fbw7 ablation promotes genetic instability that is suppressed by p53, and we show that most Fbw7⁻/⁻; p53⁻/⁻ <z:mp ids='MP_0002038'>carcinomas</z:mp> exhibit a CIN⁺ phenotype </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that Fbw7 and p53 synergistically suppress <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> that mimic advanced human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> with respect to histopathology, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and CIN </plain></SENT>
<SENT sid="9" pm="."><plain>This model thus represents a novel tool for studies of advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> as well as <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> associated with ubiquitin pathway mutations </plain></SENT>
</text></document>